Clinical Trial Update: Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 2a study evaluating PRS-080 in anemia of chronic kidney disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• PRS-080

Snippet

Sponsor: Pieris Pharmaceuticals GmbH | Conditions: Anemia of Chronic Kidney Disease | Phase 1, Phase 2 | Status: COMPLETED